![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/5925/TOC-Subject-Sample-2021-Bioscience.jpg"})
Abstract
Recent developments in dosage form design are discussed from the viewpoint that there are three key objectives in formulation; optimum biological availability, minimum side effects and maximum patient compliance. The pilocarpine Ocusert device (Alza) and the talampicillin prodrug (Beechams) are taken as examples of a physical and chemical approach to rational drug delivery.